Epileds Technologies, Inc. AI Stock Analysis
Epileds Technologies, Inc. (4956) AI Stock Analysis
Epileds Technologies, Inc.
(TWSE:4956)
Epileds scores poorly overall. The decisive factor is unprofitability: gross margin has compressed to 4.2%, operating and net results are negative, and losses in five of the past six years have steadily eroded equity and total assets. Technicals reinforce the caution, with the price below all major moving averages, a negative MACD and depressed momentum readings. Valuation is unsupportive, with a 62.9x P/E against loss-making earnings and no dividend. The partial offsets are a moderately leveraged balance sheet (0.48 debt-to-equity, equity funding ~60% of assets) and a strong cash flow rebound to NT$267.6m operating and NT$156.1m free cash flow — though these are driven largely by depreciation rather than earnings power. This remains a high-risk, cyclical turnaround candidate requiring clear evidence of margin and utilization recovery.
Epileds Technologies, Inc. (4956) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 3.29B
- Dividend Yield
- ―
- Average Volume (3M)
- 5.90M
- Price to Earnings (P/E)
- 68.5
- Beta (1Y)
- 1.33
- Revenue Growth
- 1.03%
- EPS Growth
- ―
- Country
- TW
- Employees
- 445
- Sector
- General
- Sector Strength
- 55
- Industry
- Semiconductors
Epileds Technologies, Inc. Business Overview & Revenue Model
Company Description
Epileds Technologies, Inc., established in Tainan City, Taiwan, in 2006, is a global leader specializing in the comprehensive process of researching, developing, designing, manufacturing, and distributing LED wafers and chips. Their product portfolio...
Epileds Technologies, Inc. Financial Statement Overview
Summary
Financial results are dominated by weak profitability (score 24). Gross margin has collapsed from 22.1% in 2021 to 4.2%, with an operating loss of NT$89.1m (-6.6% margin) and a net loss of NT$80.3m, marking losses in five of the past six years. Offsetting this, the balance sheet (56) is conservatively financed — debt-to-equity of 0.48 with equity funding roughly 60% of assets — though accumulated losses have eroded equity from NT$1.97bn to NT$1.62bn and ROE sits at -5.0%. Cash flow (55) rebounded sharply to NT$267.6m operating and NT$156.1m free cash flow, but that strength stems largely from heavy depreciation rather than earnings, and free cash flow has been negative in four of six years. Net: a balance-sheet-supported turnaround story with elevated earnings risk.
Income Statement
24NegativeBalance Sheet
56NeutralCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.41B | 1.35B | 1.29B | 1.13B | 1.19B | 1.76B |
| Gross Profit | 179.36M | 56.12M | 145.98M | 18.73M | 108.40M | 389.20M |
| EBITDA | 230.20M | 123.19M | 218.54M | 73.34M | 132.87M | 341.45M |
| Net Income | 47.02M | -80.28M | -21.26M | -138.75M | -72.30M | 144.09M |
Balance Sheet | ||||||
| Total Assets | 2.95B | 2.71B | 2.78B | 2.77B | 3.01B | 3.15B |
| Cash, Cash Equivalents and Short-Term Investments | 259.91M | 291.50M | 177.25M | 369.87M | 418.16M | 309.94M |
| Total Debt | 896.67M | 773.15M | 816.52M | 827.62M | 838.96M | 873.43M |
| Total Liabilities | 1.26B | 1.09B | 1.08B | 1.05B | 1.14B | 1.18B |
| Stockholders Equity | 1.69B | 1.62B | 1.70B | 1.72B | 1.86B | 1.97B |
Cash Flow | ||||||
| Free Cash Flow | 25.66M | 156.08M | -160.81M | -62.63M | 176.37M | -192.56M |
| Operating Cash Flow | 145.52M | 267.58M | -76.75M | 85.79M | 343.43M | 169.44M |
| Investing Cash Flow | -119.86M | -110.73M | -89.33M | -16.60M | -242.59M | -360.46M |
| Financing Cash Flow | 7.32M | -41.72M | -27.99M | -22.03M | -84.89M | 348.82M |
Epileds Technologies, Inc. Peers Comparison
Overall Rating
TW:804966Neutral
TW:303860Neutral
TW:359150Neutral
TW:358047Neutral
TW:495641Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 66Neutral | TWD 2.67B | 11.43 | ― | 6.19% | 4.38% | 18.31% | |
| 60Neutral | TWD 2.87B | 15.54 | ― | 6.38% | -9.99% | 1.97% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 50Neutral | TWD 3.16B | -167.81 | ― | 4.69% | 7.16% | 163.81% | |
| 47Neutral | TWD 3.49B | 52.72 | ― | 1.32% | -19.96% | -63.63% | |
| 41Neutral | TWD 3.22B | 68.47 | ― | ― | 1.03% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:4956 | Epileds Technologies, Inc. | 32.10 | 12.85 | 66.75% | |
| TW:3038 | Emerging Display Technologies Corp | 18.80 | -1.18 | -5.88% | |
| TW:3580 | UVAT Technology Co., Ltd. | 90.60 | 32.37 | 55.60% | |
| TW:3591 | Edison Opto Corporation | 24.55 | 5.20 | 26.84% | |
| TW:6775 | Entire Technology Co Ltd | 28.80 | 0.14 | 0.51% | |
| TW:8049 | Ampire Co., Ltd. | 22.60 | -1.22 | -5.11% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
